PO-0972: Interobserver variability of 3T and 1.5T MRI/CT fusion-based postimplant dosimetry of prostate brachytherapy
Norihisa Katayama(Okayama University), Shigenori Kanazawa, H Kumon, Yoshitsugu Nasu, Ryuta Tanimoto(Okayama University), Eiji Suzuki, M. Yamashita, Kensuke Bekku(Okayama University), Kuniaki Katsui(Fukuyama City Hospital), Mami Takemoto
Cited by 0
Related Papers
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
|Molecular and Clinical Oncology|2016|79
Analysis of Factors Associated With Radiation-Induced Bronchiolitis Obliterans Organizing Pneumonia Syndrome After Breast-Conserving Therapy
|International Journal of Radiation Oncology*Biology*Physics|2008|69
REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer
|International Journal of Molecular Medicine|2007|63
Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis
|Scientific Reports|2020|49
Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study
|International Journal of Radiation Oncology*Biology*Physics|2015|43